PRME Stock Predictions
| Recent PRME Stock Price | PRME Stock Predictions | |
| $5.61 |  +167.38% |
$15.00 |
| Recent PRME Analyst Ratings Breakdown, Making PRME Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 6 | 3 | 3 | 4 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 4 | 4 | 4 | 4 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.8 | 2.14 | 2.14 | 2.0 |
For the PRME stock predictions from the analysts covering Prime Medicine Inc, we have collected all of the individual PRME stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering PRME (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since PRME stock predictions may vary widely, another useful metric to consider is the median PRME stock prediction, which represents the price at which half of the analysts
made PRME stock predictions that were higher and half made PRME stock predictions that were lower. This makes for a different take on the PRME stock predictions out there, as compared to average or mean.
And that median across all the individual PRME stock predictions was: $16.0 as of 2024-05-03.
The very highest of the PRME stock predictions for one year price target was $21.0, while the very lowest of the PRME stock predictions in the analyst group was
$9.0 (with a standard deviation of $4.582). Get the latest Zacks research report on PRME — FREE
Find out: PRME next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• MC Stock Predictions
• GTHX Stock Predictions
• GOCO Stock Predictions
• QRHC Stock Predictions
• PFHD Stock Predictions
• CZZ Stock Predictions
• AMGN Stock Predictions
• TX Stock Predictions
• HONE Stock Predictions
|
|||||||||
|
|
|
|
|
Quotes delayed 20 minutes |
Free Email Alerts:
Avg. Broker Rec.
 
|
Buy (3.20 out of 4) 43rd percentile
(ranked lower than approx. 57% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
